SVRA
Savara IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.03B
P/E Ratio
—
EPS
$-0.56
Beta
0.28
52W High
$7.00
52W Low
$1.89
50-Day MA
$5.29
200-Day MA
$4.88
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
0.41
PEG Ratio
0.00
About Savara Inc
Savara Inc. is a lung disease orphan company. The company is headquartered in Austin, Texas.
Fundamentals
| Revenue (TTM) | 1,000 |
| Gross Profit (TTM) | $-81.40M |
| EBITDA | $-133.17M |
| Operating Margin | 0.00% |
| Return on Equity | -80.00% |
| Return on Assets | -40.50% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.80 |
| Price-to-Book | 5.83 |
| Price-to-Sales (TTM) | 145272.62 |
| EV/Revenue | 4269.22 |
| EV/EBITDA | -4.76 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $204.93M |
| Float | $130.12M |
| % Insiders | 2.63% |
| % Institutions | 104.17% |
Historical Volatility
HV 10-Day
56.72%
HV 20-Day
54.12%
HV 30-Day
55.72%
HV 60-Day
52.15%
HV Rank
51.6%
Volatility is currently expanding
Analyst Ratings
Consensus ($10.81 target)
2
Strong Buy6
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026